0001236031-20-000008.txt : 20200227
0001236031-20-000008.hdr.sgml : 20200227
20200227074541
ACCESSION NUMBER: 0001236031-20-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200226
FILED AS OF DATE: 20200227
DATE AS OF CHANGE: 20200227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZIMMERMAN DANIEL H
CENTRAL INDEX KEY: 0001236028
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 20658506
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2020-02-26
0
0000725363
CEL SCI CORP
CVM
0001236028
ZIMMERMAN DANIEL H
0
1
0
0
Senior Vice President
Common Stock
2020-02-26
4
P
0
923
10.83
A
114387
D
On February 26, 2020, Dr. Zimmerman purchased $10,000 worth of restricted stock directly from the Company at the closing price on February 26, 2020, the most recent closing price available.
Daniel Zimmerman
2020-02-27